These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16459435)

  • 41. Stem cell research. South Korea picks up the pieces.
    Normile D
    Science; 2006 Jun; 312(5778):1298-9. PubMed ID: 16741089
    [No Abstract]   [Full Text] [Related]  

  • 42. Koreans admit disguising stem-cell lines.
    Cyranoski D; Check E
    Nature; 2006 Jun; 441(7095):790-1. PubMed ID: 16778848
    [No Abstract]   [Full Text] [Related]  

  • 43. On cloning research, peer review and the possibility of fraud.
    Carrió I
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):235-6. PubMed ID: 16477432
    [No Abstract]   [Full Text] [Related]  

  • 44. Standards for papers on cloning.
    Nature; 2006 Jan; 439(7074):243. PubMed ID: 16421524
    [No Abstract]   [Full Text] [Related]  

  • 45. Hwang work granted patent.
    Cyranoski D
    Nature; 2008 Oct; 455(7213):571. PubMed ID: 18833236
    [No Abstract]   [Full Text] [Related]  

  • 46. Where now for stem-cell cloners?
    Check E
    Nature; 2005 Dec; 438(7071):1058-9. PubMed ID: 16371964
    [No Abstract]   [Full Text] [Related]  

  • 47. Korean stem-cell crisis deepens.
    Cyranoski D
    Nature; 2005 Nov; 438(7067):405. PubMed ID: 16306950
    [No Abstract]   [Full Text] [Related]  

  • 48. The many casualties of cloning.
    Doerflinger RM
    New Atlantis; 2006; 12():60-70. PubMed ID: 16832955
    [No Abstract]   [Full Text] [Related]  

  • 49. Research ethics and lessons from Hwanggate: what can we learn from the Korean cloning fraud?
    Saunders R; Savulescu J
    J Med Ethics; 2008 Mar; 34(3):214-21. PubMed ID: 18316467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cloning controversy.
    Nandakumar S
    Indian J Med Ethics; 2006; 3(3):93-4. PubMed ID: 17223682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alternatives to embryonic stem cells and cloning: a brief scientific overview.
    Rao RC
    Yale J Health Policy Law Ethics; 2009; 9 Suppl():603-22. PubMed ID: 19757723
    [No Abstract]   [Full Text] [Related]  

  • 52. Recent stem cell research poses several challenges.
    Wilmut I
    Cloning Stem Cells; 2006; 8(2):67-8. PubMed ID: 16776598
    [No Abstract]   [Full Text] [Related]  

  • 53. Commentary: stem cell research continues in Korea beyond the Hwang scandal.
    Kim KS
    Stem Cells; 2007 May; 25(5):1336. PubMed ID: 17272494
    [No Abstract]   [Full Text] [Related]  

  • 54. A massive snowball of fraud and deceit.
    Kerr Bernal S
    J Androl; 2006; 27(3):313-5. PubMed ID: 16474014
    [No Abstract]   [Full Text] [Related]  

  • 55. Korean stem cell scandal. Schatten: Pitt panel finds 'misbehavior' but not misconduct.
    Holden C
    Science; 2006 Feb; 311(5763):928. PubMed ID: 16484456
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic cloning set back by hype and fraud.
    Aldhous P; Coghlan A
    New Sci; 2006 Jul 1-7; 191(2558):11. PubMed ID: 17111517
    [No Abstract]   [Full Text] [Related]  

  • 57. Stem cell research is unnecessary.
    Daniel BT
    Tex Med; 2004 Sep; 100(9):8. PubMed ID: 17598321
    [No Abstract]   [Full Text] [Related]  

  • 58. Inside the Korean cloning lab.
    Park A; Gorman C
    Time; 2005 May; 165(22):54-6, 59. PubMed ID: 15954677
    [No Abstract]   [Full Text] [Related]  

  • 59. Research on human embryos, stem cells and cloning -- one year since the passing of Australian federal legislation: Australia around the world and back again.
    Magri S
    E Law; 2003 Dec; 10(4):E7. PubMed ID: 16903024
    [No Abstract]   [Full Text] [Related]  

  • 60. Stem cell research. Scientists object to Massachusetts rules.
    Holden C
    Science; 2006 Sep; 313(5792):1372. PubMed ID: 16959980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.